Outcomes of conservative therapy for young women with early endometrial adenocarcinoma

Fertility and Sterility

Volumn 93, Issue 1, 2010, Pages 283-285

  Mao, Yuyan ^a   Wan, Xiaoyun ^a   Chen, Yaxia ^a   Lv, Weiguo ^a   Xie, Xing ^a  

^a Womens Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADULT; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; ENDOMETRIUM CARCINOMA; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONAL THERAPY; HUMAN; INFERTILITY THERAPY; LIVE BIRTH; PREGNANCY; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; ENDOMETRIAL NEOPLASMS; FEMALE; FERTILITY; HUMANS; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; NEOPLASM STAGING; PREGNANCY; PREGNANCY OUTCOME; REPRODUCTIVE TECHNIQUES, ASSISTED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 72749112756     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.07.999     Document Type: Article

References (12)

1. Soliman P.T., Oh J.G., Schmeler K.M., Suu C.C., Slomovitz B.M., Gershenson D.M., et al. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol 105 (2005) 575-580
2. Wang C.B., Wang C.J., Huang H.J., Hsueh S., Chou H.H., Soonq Y.K., et al. Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Cancer 94 (2002) 2192-2198
3. Kempson R.L., and Polorny G.E. Adenocarcinoma of the endometrium in women aged forty and younger. Cancer 21 (1968) 650-662
4. Kim Y.B., Holschneider C.H., Ghosh K., Nieberg R.K., and Montz F.J. Progesterone alone as primary treatment of endometrial carcinoma in premenopausal women: report of seven cases and review of the literature. Cancer 79 (1997) 320-327
5. Randall T.C., and Kurman R.J. Progesterone treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 90 (1997) 434-440
6. Duska L.R., Garrett A., Rueda B.R., Haas J., Chang Y., and Fuller A.F. Endometrial cancer in women 40 years old or younger. Gynecol Oncol 83 (2001) 388-393
7. Imai M., Jobo T., Sato R., Kawaguchi M., and Kuramoto H. Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus: usefulness and limitations. Eur J Gynaecol Oncol 22 (2001) 217-220
8. Kaku T., Yoshikawa H., Tsuda H., Sakamoto A., Fukunaga M., Kuwabara Y., et al. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome. Cancer Lett 167 (2001) 39-48
9. Niwa K., Tagami K., Lian Z., Onogi K., Mori H., and Tamaya T. Outcome of fertility-preserving treatment in young women with endometrial carcinomas. BJOG 112 (2005) 317-320
10. Gotlieb WH, Beiner ME, Shalmon B, Korach Y, Segal Y, Zmira N, et al. Outcome of frtility-sparing treatment with progesterones in young patients with endometrial.
11. Ramirez P.T., Frumovitz M., Bodurka D.C., Sun C.C., and Levenback C. Hornomal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol 95 (2004) 133-138
12. Yahata T., Fujita K., Aoke Y., and Tanaka K. Long-term conservative therapy for endometrial adenocarcinoma in young women. Hum Reprod 21 (2006) 1070-1075